Jujiafenhuangquan Yindaoshuan
NDC Package 84149-0102-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Jujiafenhuangquan Yindaoshuan is 【Precaution】1. Marketed by Heilongjiang Tianlong Pharmaceutical Co Ltd, this product is identified by NDC 84149-0102.

Identification & Billing

NDC Package Code
84149-0102-3
Package Description
5 mg in 1 BOTTLE
Product Code
84149-0102
11-Digit Billing Format
84149010203

Clinical Specifications

Proprietary Name
Jujiafenhuangquan Yindaoshuan
Dosage Form
-
Usage Information
【Precaution】1. External use only, should not be taken orally.2. This product should avoid contact with eyes.3. This product will accelerate and enhance the repair process. If the necrotic tissue falls off from the focus, sometimes even a large sheet falls off. Do not panic.4. Stop treatment during menstruation. Avoid sexual life during treatment. Do not use irritating soap to clean the affected area.5. Cotton fabric and leather shall be washed with water immediately before the preparation is dry, when the solution contacting with them.6. Spots on the vaginal suppository are the natural phenomena produced by its matrix, which do not affect the use and efficacy of the drug, nor affect its tolerance.【Medication for pregnant women and lactating women】 During pregnancy, especially in the third trimester, any cervical treatment should be avoided, and the Policresulen suppository is no exception. At this time, the potential harm of the drug to the mother and baby should be fully considered. Although the animal test shows that the drug has no teratogenic effect, the results of the human test have not been obtained. It is unclear whether the milk of lactating women will contain the active ingredient of this medicine.【Children Medication】The safety and efficacy of children patients have not been studied.【Geriatric Medication】The safety and efficacy of elderly patients have not been studied.【Drug Interactions】Policresulen can only be used locally. Since the interaction with other drugs cannot be ruled out, it is avoided to use more than two drugs at the same place at the same time.

Regulatory & Marketing

Labeler Name
Heilongjiang Tianlong Pharmaceutical Co Ltd
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
03-06-2024
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84149-0102-3 identifies a specific commercial package of 5 mg in 1 bottle of Jujiafenhuangquan Yindaoshuan, labeled by Heilongjiang Tianlong Pharmaceutical Co Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Heilongjiang Tianlong Pharmaceutical Co Ltd on March 06, 2024. The current certification is valid through December 31, 2025.

How is this Heilongjiang Tianlong Pharmaceutical Co Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84149010203. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
84149-0102-3
11-Digit CMS (5-4-2)
84149-0102-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.